Bruno Guy
16Patents
6h-index
22Co-inventors
62Inventor score
Filing activity: Jan 19, 1996 → Feb 6, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6126938A | Methods for inducing a mucosal immune response | Emerging Cross-Sectional Technologies | 33 | Expired |
| US7641908B2 | Dengue serotype 2 attenuated strain | Emerging Cross-Sectional Technologies | 10 | Active |
| US7718358B2 | Method of immunization against the 4 dengue serotypes | Emerging Cross-Sectional Technologies | 7 | Active |
| US7641907B2 | Dengue serotype 1 attenuated strain | Emerging Cross-Sectional Technologies | 7 | Active |
| US7718359B2 | Method of immunization against the 4 serotypes of dengue fever | Emerging Cross-Sectional Technologies | 7 | Active |
| US7235243B2 | Immunological combination compositions and methods | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6576244B1 | LT and CT in parenteral immunization methods against helicobacter infection | Human Necessities | 5 | Expired |
| US6379675B1 | Immunological combination compositions and methods | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7718357B2 | Method of immunization against the 4 dengue serotypes | Emerging Cross-Sectional Technologies | 5 | Active |
| US8067565B2 | Dengue serotype 1 attenuated strain | Emerging Cross-Sectional Technologies | 4 | Active |
| US8067566B2 | Dengue serotype 2 attenuated strain | Emerging Cross-Sectional Technologies | 4 | Active |
| US9169298B2 | Dengue serotype 1 attenuated strain | Emerging Cross-Sectional Technologies | 3 | Active |
| US8795688B2 | Dengue serotype 2 attenuated strain | Emerging Cross-Sectional Technologies | 3 | Active |
| US6984385B2 | Immunological combination compositions and methods | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9937252B2 | Induction of cross-reactive cellular response against rhinovirus antigens | Chemistry; Metallurgy | 0 | Active |
| US8506971B2 | Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.